Latest Product Development News

Vonex Limited reports solid operational improvements and customer satisfaction in Q2 FY25, while endorsing Maxo Telecommunications’ takeover offer and planning a $13 million capital raise to manage debt.

Hydrix Limited has extended its contract with Paul Hartmann AG, adding $2.8 million in revenue and reinforcing its international growth strategy.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.

RocketDNA has reported its strongest quarter yet, breaking the $2 million revenue barrier and marking its first international export of the xBot® autonomous drone platform to a major African mining operation.

Myer Holdings Limited is advancing a transformative merger with Premier Investments' Apparel Brands, aiming to create a $4 billion retail powerhouse. Shareholders overwhelmingly support the deal, which promises enhanced scale, diversified earnings, and strategic growth opportunities.

Icetana Limited has announced a fully underwritten renounceable entitlement offer to raise approximately $2.65 million, aiming to bolster sales, marketing, and product development efforts. The offer, priced at $0.02 per new share, opens on February 3 and closes on February 14, 2025.

Icetana Limited reports a sharp decline in cash flow for the December quarter, offset by plans for an underwritten rights issue to bolster funding and expectations of improved customer receipts in coming quarters.

Icetana Limited reports a challenging December quarter with declining revenues but secures significant new contracts and launches a fully underwritten $2.65 million rights issue.

Icetana AI has launched a fully underwritten renounceable entitlement offer to raise approximately A$2.65 million, aiming to bolster sales, marketing, and product development. The company is also nearing a potential $1.77 million deal linked to its Baghdad Safe City project in Iraq.

Archer Materials has been granted a pivotal US patent for its Biochip technology, safeguarding its intellectual property and positioning the company for strategic entry into the lucrative US medical diagnostics market.

Nanoveu has completed due diligence and is set to finalise its acquisition of EMASS, integrating cutting-edge AI-enabled SoC technology into its EyeFly3D™ platform to expand applications across wearables, IoT, and smart devices.